These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Trial of daunomycin in acute promyelocytic leukemia of childhood: a Southwest Oncology Group Study. van Eys J; Steuber P; Haggard ME; Sabio H; Duncan M Am J Pediatr Hematol Oncol; 1981; 3(3):301-3. PubMed ID: 7025685 [TBL] [Abstract][Full Text] [Related]
7. [About the acute promyelocytic leukaemia (author's transl)]. Bernard J; Flandrin G Nouv Rev Fr Hematol; 1973; 13(6):755-60. PubMed ID: 4280041 [No Abstract] [Full Text] [Related]
9. Intravascular coagulation and fibrinolysis syndrome (ICF) in acute non-promyelocytic leukemia. Kotschy M; Kotlarek-Haus S; Podolak-Dawidziak M; Nowicka J; Dzik T Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(1):65-73. PubMed ID: 6157626 [TBL] [Abstract][Full Text] [Related]
10. [Acute promyelocytic leukemia. Review of the literature]. Virgolini L Minerva Med; 1984 Jul; 75(30-31):1797-802. PubMed ID: 6090991 [TBL] [Abstract][Full Text] [Related]
11. [Disseminated intravascular coagulation (D.I.C.) and fibrinolysis in patients with acute leukemia (author's transl)]. Bunjevacki G; Sultan Y; Izraël V Nouv Rev Fr Hematol (1978); 1979 Jan; 20(4):575-84. PubMed ID: 286287 [TBL] [Abstract][Full Text] [Related]
12. Acute promyelocytic leukemia: a model for understanding the role of the malignant cell in hemostasis. Gralnick HR; Tan HK Hum Pathol; 1974 Nov; 5(6):661-73. PubMed ID: 4607877 [No Abstract] [Full Text] [Related]
13. Daunorubicin-prednisone in the treatment of acute nonlymphocytic leukemia. Peterson BA; Bloomfield CD; Theologides A; Kennedy BJ Cancer Treat Rep; 1981; 65 Suppl 4():29-33. PubMed ID: 6955011 [TBL] [Abstract][Full Text] [Related]
14. The effect of thioguanine on a combination of daunorubicine, cytarabine and prednisone in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group. Scand J Haematol; 1979 Aug; 23(2):124-8. PubMed ID: 291122 [TBL] [Abstract][Full Text] [Related]
15. Disseminated intravascular coagulation in acute leukemia at presentation and during induction therapy. Dixit A; Chatterjee T; Mishra P; Kannan M; Choudhry DR; Mahapatra M; Choudhry VP; Saxena R Clin Appl Thromb Hemost; 2007 Jul; 13(3):292-8. PubMed ID: 17636191 [TBL] [Abstract][Full Text] [Related]
17. Primary therapy of acute promyelocytic leukemia: results of amsacrine- and daunorubicin-based therapy. Arlin Z; Kempin S; Mertelsmann R; Gee T; Higgins C; Jhanwar S; Chaganti RS; Clarkson B Blood; 1984 Jan; 63(1):211-2. PubMed ID: 6580926 [TBL] [Abstract][Full Text] [Related]
18. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases]. Rodríguez Gómez M; López Fernández MF; Batlle J Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380 [TBL] [Abstract][Full Text] [Related]
19. [Heparin as treatment for hypercoagulability syndrome in a case of acute promyelocytic leukemia]. Pizzuto J; Gonzalez Llaven J; Uribe Cortes JA Sangre (Barc); 1969; 14(3):363-70. PubMed ID: 5288844 [No Abstract] [Full Text] [Related]
20. [Pathogenesis and pathologic physiology of disseminated intravascular coaguration (DIC) in patients with acute promyelocytic leukemia (author's transl)]. Ando Y; Watanabe K Rinsho Ketsueki; 1976 Apr; 17(4):389-95. PubMed ID: 1066493 [No Abstract] [Full Text] [Related] [Next] [New Search]